Bibliography
- TRAVIS J: Reviving the antibiotic miracle? Science (1994) 264:360–362.
- HANCOCK REW, LEHRER RI: Cationic peptides: a new source of antibiotics. Trends Biotech. (1998) 16:82–88.
- BOMAN HG: Peptide antibiotics and their role in innate immunity. Ann. Rev. Immunol. (1995) 13:61–92.
- HANCOCK REW, FALLA T, BROWN MM: Cationic bacteri-cidal peptides. Adv. Microbial Physiol. (1995) 37:135–175.
- KADALAYIL L, PETERSEN UM, ENGSTROM Y: Adjacent GATA and kappa 3-like motifs regulate the expression of a drosophila immune gene. Nucl. Acids Res. (1997) 25:1233–1239.
- HARDER J, BARTELS J, CHRISTOPHERS E, SCHRODER JM:A peptide antibiotic from human skin. Nature (1997) 387:861–863.
- STOLZENBERG ED, ANDERSON GM, ACKERMANN MR etal.: Epithelial antibiotic induced in states of disease. Proc. Natl. Acad. Sci. USA (1997) 94:8686–8690.
- GANZ T, LEHRER RI: Antimicrobial peptides of leuko-cytes. Curr. Opin. Hematol. (1997) 4:53–58.
- HANCOCK REW: Peptide antibiotics. Lancet (1997) 349:418–422.
- GOLDMAN MJ, ANDERSON GM, STOLTZENBERG ED eta].: Human beta-defensin-1 is a salt sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell (1997) 88 :553–560.
- SMITH JJ, TRAVIS SM, GREEBERG EP, WALSH MJ: Cystic Fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell (1996) 85:229–236.
- STEINBERG DA, HURST MA, FUJII CA eta].: Protegrin-1: a broad spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. (1997) 41:1738–1742.
- KONDEJEWSKI LH, FARMER SW, WISHART DS et al.:Gramicidin S is active against both Gram-positive and Gram-negative bacteria. IntL j Pept. Prot. Res. (1996) 47:460–466.
- DELVES-BROUGHTON J, BLACKBURN P, EVANS RJ, HUGENHOLTZ J: Applications of the bacteriocin nisin. Antonie van Leeuwenhoek (1996) 69:193–202.
- ROGY MA, OLDENBURG HSA, CALVANO SE et al.: Therole of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock. J. Clin. Immunol. (1994) 14:120–133.
- GOUGH M, HANCOCK REW, KELLY NM: Anti-endotoxicpotential of cationic peptide antimicrobials. Infect. Im-mun. (1996) 64:4922–4927.
- DARVEAU RP, CUNNINGHAM MD, SEAFORD CL et al.:Beta-lactam antibiotics potentiate magainin 2 antimi-crobial activity in vitro and in vivo. Antimicrob. Agents Chemother. (1991) 35:1153–1159.
- SILVESTRO L, GUPTA K, WEISER JN, AXELSEN PH: The concentration-dependent membrane activity of ce-cropin A. Biochemistry (1997) 36:11452–11460.
- FALLA T, HANCOCK REW: Improved activity of a syn-thetic indolicidin analogue. Antimicrob. Agents Chemo-ther. (1997) 41:771–775.
- APPENZELLER L, LIME, WONG P eta].: In vivo fundicidalactivity of optimized domain III peptides derived from bactericidal/permeability-increasing protein BPI. ICAAC (1996) September 17–20 36:F187.
- NAKASHIMA H, MASUDA M, MURAKAMI T et al.: Anti-human immunodeficiency virus activity of a novel synthetic peptide, 122 QTyr-5, 12, Lys-7] Polyphe-musin II): a possible inhibitor of virus-cell fusion. Anti-microb. Agents Chemother. (1992) 36:1249–1255.
- JACOB L, ZASLOFF M: Potential therapeutic applica-tions of magainins and other antimicrobial agents of animal origin. Ciba Found. Symp. (1994) 186:197–223.
- MOORE AJ, DEVINE DA, BIBBY MC: Preliminary experi-mental anti-cancer activity of cecropin B. Peptide Res. (1994) 7:265–269.
- RODRIGUEZ MC, ZAMUDIO F, TORRES JA eta].: Effect of a cecropin-like synthetic peptide (Shiva -3) on the sporogenic development of Plasmodium berghei. Expd. Parasitol. (1995) 80:596–604.
- SEARS PM, SMITH BS, STEWART WK eta].: Evaluation of a nisin-based germicidal formulation on teat skin of live cows. J. Dairy Sci. (1992) 75:3185–3190.
- NOS-BAR BERA S, PORTOLES M, MORILLA A eta].: Effect of hybrid peptides of cecropin A and melittin in an ex-perimental model of bacterial keratitis. Cornea (1997) 16:101–106.
- AHMAD I, PERKINS WR, LUPAN DM eta].: Liposomal en-trapment of the neutrophil-derived peptide indoli-cidin endows it with in vivo antifungal activity. Biochim. Biophys. Acta (1995) 1237:109–114.
- KOHN TF, AMMONS WS, HOROWITZ A eta].: Protectiveeffect of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in ex-perimental endotoxaemia. J. Infect. Dis. (1993) 168:1307–1310.
- BATTAFARANO RJ, DAHLBERG PS, RATZ CA et al.: Pep-tide derivatives of 3 distinct lipopolysaccharide bind-ing proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro. Surgery (1995) 118:318–324.
- JENSEN T, PEDERSEN SS, GARNE S eta].: Colistin inhala-tion therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimi-crob. Chemother. (1987) 19:831–838.